Evidence map›Paper›PMID 39087052›Full record

ArticleIndian journal of orthopaedics2024

Deep Angiomyxoma of the Knee: a Rare Case Report.

J Pranav, Shivam Bansal, Saptarshi Barman, Nivesh Kumawat, Rohan Gowda, Mohit Dhingra, Arvind Kumar

Abstract readCase Reports
In one paragraph

Article in Indian journal of orthopaedics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

J PranavDepartment of Orthopaedics, All India Institute of Medical Sciences, Rishikesh, India.ORCID 0000-0003-3130-7286
Shivam BansalDepartment of Orthopaedics, All India Institute of Medical Sciences, Rishikesh, India.ORCID 0000-0002-3602-2952
Saptarshi BarmanDepartment of Orthopaedics, All India Institute of Medical Sciences, Rishikesh, India.ORCID 0000-0001-6083-5446
Nivesh KumawatDepartment of Orthopaedics, All India Institute of Medical Sciences, Rishikesh, India.ORCID 0009-0001-7613-5599
Rohan GowdaDepartment of Orthopaedics, All India Institute of Medical Sciences, Rishikesh, India.ORCID 0009-0000-7904-4847
Mohit DhingraDepartment of Orthopaedics, All India Institute of Medical Sciences, Rishikesh, India.ORCID 0000-0001-6798-9173
Arvind KumarDepartment of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Rishikesh, India.ORCID 0000-0002-3614-6074

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Deep angiomyxoma (DAM) is a slow-growing benign tumor with high risk of local recurrence after surgical resection. Although DAM in a lower extremity is extremely rare, clinicians must be aware of its possible occurrence. Suspicion can be made based on clinical examination and radiological imaging but final diagnosis is confirmed on histopathological examination and immunohistochemistry. We intend to present an extremely rare case of DAM in the knee, managed successfully with marginal excision. Case Presentation: A 4-year-old male child presented with the complains of a painless, progressively increasing, soft, non-tender, and fluctuant swelling in his right knee. The plain radiograph showed a non-calcified soft-tissue swelling and MRI revealed a multi-loculated cystic lesion with multiple septations. A pre-operative diagnosis of a benign cystic lesion was made. It was managed by marginal excision of the tumor and a histological diagnosis of DAM was made. IHC staining showed positivity for SMA, CD34 and vimentin were focally positive, while desmin and calponin were negative. At 12 months of follow-up, the patient had a normal painless gait and full knee ROM, without any local recurrence. Conclusion: DAM is a rare tumor which is often misdiagnosed. In this report, we present a rare case of benign cystic lesion which turned out to be DAM on HPE of resected specimen. Marginal excision of this lesion revealed good outcomes with no recurrence until 12 months of final follow-up. With this, we conclude that surgical excision should be the gold standard in cases of DAM.

Indexed as

Angiomyxomabenign tumourlocal recurrencemesenchymal tumourrecurrencesurgical resection

Identifiers

PMID39087052
PMCPMC11286878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.